FDA
approval
· 2016-09-02
FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin Pharmaceuticals' supplemental application for a generic fixed-dose combination of telmisartan and amlodipine for hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)